Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Salm

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Immuno-Oncology Technology|June 27, 2022
Adoptive cell therapy with tumour-infiltrating lymphocytes: the emerging importance of clonal neoantigen targets for next-generation products in non-small cell lung cancerJane Robertson, Max Salm, Markus Dangl
Nature Cancer|April 15, 2024
Author Correction: Breaking the performance ceiling for neoantigen immunogenicity predictionHugh O'Brien, Max Salm, Laura T Morton, et al.
Nature Cancer|December 15, 2023
Breaking the performance ceiling for neoantigen immunogenicity predictionHugh O'Brien, Max Salm, Laura T Morton, et al.
Genome Biology|October 2, 2014
Deciphering clonality in aneuploid breast tumors using SNP array and sequencing dataIngrid M Lönnstedt, Franco Caramia, Jason Li, et al.
Plos Computational Biology|November 11, 2024
A modular protein language modelling approach to immunogenicity predictionHugh O'Brien, Max Salm, Laura T Morton, et al.
Cancer Discovery|May 25, 2015
Tracking the genomic evolution of esophageal adenocarcinoma through neoadjuvant chemotherapyNirupa Murugaesu, Gareth A Wilson, Nicolai J Birkbak, et al.
Science (New York, N.Y.)|October 11, 2014
Spatial and temporal diversity in genomic instability processes defines lung cancer evolutionElza C de Bruin, Nicholas McGranahan, Richard Mitter, et al.
Nature Communications|March 20, 2015
Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolutionMichal Kovac, Carolina Navas, Stuart Horswell, et al.
Plos Biology|July 9, 2014
Tracking genomic cancer evolution for precision medicine: the lung TRACERx studyMariam Jamal-Hanjani, Alan Hackshaw, Yenting Ngai, et al.
Cell|April 17, 2018
Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx RenalSamra Turajlic, Hang Xu, Kevin Litchfield, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Immuno-Oncology Technology|June 27, 2022
Adoptive cell therapy with tumour-infiltrating lymphocytes: the emerging importance of clonal neoantigen targets for next-generation products in non-small cell lung cancerJane Robertson, Max Salm, Markus Dangl
Nature Cancer|April 15, 2024
Author Correction: Breaking the performance ceiling for neoantigen immunogenicity predictionHugh O'Brien, Max Salm, Laura T Morton, et al.
Nature Cancer|December 15, 2023
Breaking the performance ceiling for neoantigen immunogenicity predictionHugh O'Brien, Max Salm, Laura T Morton, et al.
Genome Biology|October 2, 2014
Deciphering clonality in aneuploid breast tumors using SNP array and sequencing dataIngrid M Lönnstedt, Franco Caramia, Jason Li, et al.
Plos Computational Biology|November 11, 2024
A modular protein language modelling approach to immunogenicity predictionHugh O'Brien, Max Salm, Laura T Morton, et al.
Cancer Discovery|May 25, 2015
Tracking the genomic evolution of esophageal adenocarcinoma through neoadjuvant chemotherapyNirupa Murugaesu, Gareth A Wilson, Nicolai J Birkbak, et al.
Science (New York, N.Y.)|October 11, 2014
Spatial and temporal diversity in genomic instability processes defines lung cancer evolutionElza C de Bruin, Nicholas McGranahan, Richard Mitter, et al.
Nature Communications|March 20, 2015
Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolutionMichal Kovac, Carolina Navas, Stuart Horswell, et al.
Plos Biology|July 9, 2014
Tracking genomic cancer evolution for precision medicine: the lung TRACERx studyMariam Jamal-Hanjani, Alan Hackshaw, Yenting Ngai, et al.
Cell|April 17, 2018
Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx RenalSamra Turajlic, Hang Xu, Kevin Litchfield, et al.
Pageof 2